MCI and periodontal disease at June 11, 2019

By Ross Perry | June 11, 2019

About the Author

Ross has served as CHX’s CEO and a director for 15 years. He is responsible for Prevora’s first-in-class regulatory approvals in Europe and Canada, and for building strategic alliances.

Subscribe to Blog

* indicates required

Email Address *

First Name

Last Name

Sitemap

About
Our Medicine
R&D
Collaborate
Investors
News
Contact Us

Copyright, CHX Technologies Inc., 2018. Website Designed by Degroot Design. Privacy Policy | Terms & Conditions| Cookie Policy